Vista Clinical Diagnostics, Access Dermpath and Advanced Clinical Laboratories allegedly billed for clinical laboratory services using diagnosis codes that were generated by a macro and inserted into beneficiaries’ reimbursement submissions, according to a July 11 Justice Department news release.
The code manipulation allegedly occurred between 2017 and 2021, according to the release.
The settlement includes claims brought under the False Claims Act’s whistleblower provisions. The whistleblower, a former Vista Clinical Diagnostics employee, will receive more than $440,000 of the proceeds from the settlement.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.